| Balance Sheets | 2025-10-31 | 2025-07-31 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 1,951,103 | 2,792,231 | ||
| Inventory, net | 657,285 | 649,507 | ||
| Prepaid expenses | 221,642 | 418,658 | ||
| Deferred offering costs | 705,499 | 515,825 | ||
| Other current assets | 257,959 | 40,374 | ||
| Total current assets | 3,793,488 | 4,416,595 | ||
| Property and equipment, gross | 604,461 | 600,907 | ||
| Less accumulated depreciation | 551,475 | 544,469 | ||
| Property and equipment, net | 52,986 | 56,438 | ||
| Capitalized software | 198,703 | - | ||
| Intangible assets, net | 1,629,307 | 1,617,091 | ||
| Right-of-use assets, net | 321,633 | 347,062 | ||
| Total assets | 5,996,117 | 6,437,186 | ||
| Accounts payable | 317,390 | 283,225 | ||
| Accrued expenses | 311,184 | 599,287 | ||
| Accrued interest expense | 160,261 | 251,366 | ||
| Operating lease liabilities, current portion | 128,977 | 124,173 | ||
| Notes payable | 500,000 | 1,541,120 | ||
| Other current liabilities | 148,572 | 215,334 | ||
| Total current liabilities | 1,566,384 | 3,014,505 | ||
| Operating lease liabilities, long-term | 247,263 | 281,570 | ||
| Total long-term liabilities | 247,263 | 281,570 | ||
| Total liabilities | 1,813,647 | 3,296,075 | ||
| Convertible preferred stock, value-Series CConvertible Preferred Stock | 380 | 380 | ||
| Convertible preferred stock, value-Series DConvertible Preferred Stock | 580 | 430 | ||
| Common stock, 0.001 par value, 500,000,000 shares authorized 3,071,135 shares issued and outstanding as of october 31, 2025 and 1,119,107 shares issued and outstanding as of april 30, 2025 | 3,071 | 2,281 | ||
| Additional paid-in capital | 84,711,837 | 81,320,649 | ||
| Accumulated deficit | -80,533,398 | -78,182,629 | ||
| Total stockholders' equity | 4,182,470 | 3,141,111 | ||
| Total liabilities and stockholders' equity | 5,996,117 | 6,437,186 | ||
HeartSciences Inc. (HSCSW)
HeartSciences Inc. (HSCSW)